Hologic has seen a sharp downtrend recently that could be a bottom, but isn’t necessarily so. Because the bottom in question came without abnormal volume (which would indicate bulls were fighting to keep the stock above that support line), Fitzpatrick wasn’t so sure. If you’re taking a long position in HOLX, be careful.

womans health care

The derivatives are more powerful than the stocks they encompass -- Nasdaq or S&P futures -- but they are not more powerful than the companies themselves. Genzyme (GENZ), Gilead (GILD), Hologic (HOLX), Starbucks (SBUX), they will all get killed. Is that right? I don't think so.

Yes, I know they had a lousy quarter. I am a bit upset too....

Yet, I think their story is "decent"... I think it is due for a rebound...

From a recent Mad Money show:

"When their CEO comes back on the show, only then will I recommend it. He came on when things were good, now they're not and that makes me nervous."

From a recent Mad Money show:

"I think they're getting their arms around what's wrong. I am in the 'don't buy' camp for right now. It's too dicey."

leader in women's health applications

following it

leader in womans medical care

Cramer healcare play

unbelievable downward turn to what seemed to be a good company

growth

Health care

Has not done well. I think it will.